BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 33561723)

  • 1. A Population-based Analysis of Lymph Node Metastasis in Extremity Soft Tissue Sarcoma: An Update.
    Gusho CA; Fice MP; O'Donoghue CM; Gitelis S; Blank AT
    J Surg Res; 2021 Jun; 262():121-129. PubMed ID: 33561723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognosis of lymph node metastasis in soft tissue sarcoma.
    Behranwala KA; A'Hern R; Omar AM; Thomas JM
    Ann Surg Oncol; 2004 Jul; 11(7):714-9. PubMed ID: 15231526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Head and neck soft tissue sarcomas: unique lack of significance of synchronous node metastases.
    Smith VA; Overton LJ; Lentsch EJ
    J Surg Oncol; 2012 Dec; 106(7):837-43. PubMed ID: 22605652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synovial Sarcoma Is Not Associated With a Higher Risk of Lymph Node Metastasis Compared With Other Soft Tissue Sarcomas.
    Jacobs AJ; Morris CD; Levin AS
    Clin Orthop Relat Res; 2018 Mar; 476(3):589-598. PubMed ID: 29529647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Curability of patients with lymph node metastases from extremity soft-tissue sarcoma.
    Basile G; Mattei JC; Alshaygy I; Griffin AM; Catton CN; Chung PW; Shultz DB; Razak ARA; Demicco EG; Ferguson PC; Wunder JS
    Cancer; 2020 Dec; 126(23):5098-5108. PubMed ID: 32910462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors of regional lymph node (RLN) metastasis among patients with bone sarcoma and survival of patients with RLN-positive bone sarcoma.
    Dong Y; Wu W; Kang H; Xiong W; Ye D; Fang Z; Guan H; Liao H; Li F
    Ann Transl Med; 2021 Jan; 9(1):48. PubMed ID: 33553341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymph Node Sampling and Survival in Child and Adolescent Extremity Soft-Tissue Sarcoma.
    Brady AC; Picado O; Tashiro J; Sola JE; Perez EA
    J Surg Res; 2019 Sep; 241():205-214. PubMed ID: 31028942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of lymph node disease in extremity soft-tissue sarcomas: a population-based analysis.
    Johannesmeyer D; Smith V; Cole DJ; Esnaola NF; Camp ER
    Am J Surg; 2013 Sep; 206(3):289-95. PubMed ID: 23806824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for lymph node metastasis of soft tissue sarcomas of the head, neck, and extremities, and the clinical significance of negative lymph node dissection.
    Liu QK; Yu XJ; Wang YG; Lu R; Wang SX; Xu HR; Kang H
    J Orthop Surg Res; 2022 Mar; 17(1):167. PubMed ID: 35303897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of T and N Categories of the American Joint Commission on Cancer, 8th Edition, With Metastasis and Survival in Patients With Orbital Sarcoma.
    Sa HS; Rubin ML; Ning J; Li W; Tetzlaff MT; McGovern SL; Paulino AC; Herzog CE; Gill JB; Esmaeli B
    JAMA Ophthalmol; 2020 Apr; 138(4):374-381. PubMed ID: 32105303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymph node metastases in soft tissue sarcomas: a single center analysis of 1,597 patients.
    Daigeler A; Kuhnen C; Moritz R; Stricker I; Goertz O; Tilkorn D; Steinstraesser L; Steinau HU; Lehnhardt M
    Langenbecks Arch Surg; 2009 Mar; 394(2):321-9. PubMed ID: 18594854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is There an Association Between Insurance Status and Survival and Treatment of Primary Bone and Extremity Soft-tissue Sarcomas? A SEER Database Study.
    Smartt AA; Jang ES; Tyler WK
    Clin Orthop Relat Res; 2020 Mar; 478(3):527-536. PubMed ID: 31390340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-Rhabdomyosarcoma Soft Tissue Sarcomas in Children: A Surveillance, Epidemiology, and End Results Analysis Validating COG Risk Stratifications.
    Waxweiler TV; Rusthoven CG; Proper MS; Cost CR; Cost NG; Donaldson N; Garrington T; Greffe BS; Heare T; Macy ME; Liu AK
    Int J Radiat Oncol Biol Phys; 2015 Jun; 92(2):339-48. PubMed ID: 25968827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic implications of PD-L1 expression in patients with soft tissue sarcoma.
    Kim C; Kim EK; Jung H; Chon HJ; Han JW; Shin KH; Hu H; Kim KS; Choi YD; Kim S; Lee YH; Suh JS; Ahn JB; Chung HC; Noh SH; Rha SY; Kim SH; Kim HS
    BMC Cancer; 2016 Jul; 16():434. PubMed ID: 27393385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic factors affecting survival in metastatic soft tissue sarcoma: an analysis of 110 patients.
    Iqbal N; Shukla NK; Deo SV; Agarwala S; Sharma DN; Sharma MC; Bakhshi S
    Clin Transl Oncol; 2016 Mar; 18(3):310-6. PubMed ID: 26243399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regional lymph node metastases in patients with soft tissue sarcomas of the extremities, what are the therapeutic consequences?
    Gaakeer HA; Albus-Lutter CE; Gortzak E; Zoetmulder FA
    Eur J Surg Oncol; 1988 Apr; 14(2):151-6. PubMed ID: 3360156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can Multistate Modeling of Local Recurrence, Distant Metastasis, and Death Improve the Prediction of Outcome in Patients With Soft Tissue Sarcomas?
    Posch F; Leitner L; Bergovec M; Bezan A; Stotz M; Gerger A; Pichler M; Stöger H; Liegl-Atzwanger B; Leithner A; Szkandera J
    Clin Orthop Relat Res; 2017 May; 475(5):1427-1435. PubMed ID: 28083752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regional Lymph Node Involvement Is Associated With Poorer Survivorship in Patients With Chondrosarcoma: A SEER Analysis.
    Wan L; Tu C; Li S; Li Z
    Clin Orthop Relat Res; 2019 Nov; 477(11):2508-2518. PubMed ID: 31283732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sentinel Lymph Node Biopsy for Extremity and Truncal Soft Tissue Sarcomas: A Systematic Review of the Literature.
    Keung EZ; Krause KJ; Maxwell J; Morris CD; Crago AM; Houdek MT; Kane J; Lewis V; Callegaro D; Miller B; Lazar AJ; Gladdy R; Raut CP; Fabbri N; Al-Refaie W; Fairweather M; Wong SL; Roland CL
    Ann Surg Oncol; 2023 Feb; 30(2):958-967. PubMed ID: 36307665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparing mortality of vaginal sarcoma, squamous cell carcinoma, and adenocarcinoma in the surveillance, epidemiology, and end results database.
    Ghezelayagh T; Rauh-Hain JA; Growdon WB
    Obstet Gynecol; 2015 Jun; 125(6):1353-1361. PubMed ID: 26000506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.